MDM2 and cancer: In our model, RSL1D1 acts as an oncoprotein that negatively regulate p53 activity by stabilizing HDM2 mRNA and recruiting p53 to HDM2 via direct interaction for ubiquitination and degradation, thereby leading to cancer cell proliferation and survival.